Subanesthetic doses of ketamine stimulate psychosis in schizophrenia AC Lahti, B Koffel, D LaPorte, CA Tamminga Neuropsychopharmacology 13 (1), 9-19, 1995 | 1182 | 1995 |
Effects of ketamine in normal and schizophrenic volunteers AC Lahti, MA Weiler, BAT Michaelidis, A Parwani, CA Tamminga Neuropsychopharmacology 25 (4), 455-467, 2001 | 825 | 2001 |
Decisional capacity for informed consent in schizophrenia research WT Carpenter, JM Gold, AC Lahti, CA Queern, RR Conley, JJ Bartko, ... Archives of general Psychiatry 57 (6), 533-538, 2000 | 645 | 2000 |
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network S Gulsuner, T Walsh, AC Watts, MK Lee, AM Thornton, S Casadei, ... Cell 154 (3), 518-529, 2013 | 602 | 2013 |
Ketamine activates psychosis and alters limbic blood flow in schizophrenia AC Lahti, HH Holcomb, DR Medoff, CA Tamminga Neuroreport 6 (6), 869-872, 1995 | 550 | 1995 |
Probing the human hippocampus using rCBF: contrasts in schizophrenia DR Medoff, HH Holcomb, AC Lahti, CA Tamminga Hippocampus 11 (5), 543-550, 2001 | 301 | 2001 |
Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine LE Hong, A Summerfelt, RW Buchanan, P O'donnell, GK Thaker, ... Neuropsychopharmacology 35 (3), 632-640, 2010 | 265 | 2010 |
SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma SM Robert, SC Buckingham, SL Campbell, S Robel, KT Holt, ... Science translational medicine 7 (289), 289ra86-289ra86, 2015 | 250 | 2015 |
Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder—a systematic review of the magnetic resonance neuroimaging literature B Birur, NV Kraguljac, RC Shelton, AC Lahti NPJ schizophrenia 3 (1), 15, 2017 | 237 | 2017 |
Neurometabolites in schizophrenia and bipolar disorder—a systematic review and meta-analysis NV Kraguljac, M Reid, D White, R Jones, J den Hollander, D Lowman, ... Psychiatry Research: Neuroimaging 203 (2-3), 111-125, 2012 | 231 | 2012 |
Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia NV Kraguljac, DM White, MA Reid, AC Lahti JAMA psychiatry 70 (12), 1294-1302, 2013 | 208 | 2013 |
Sequential regional cerebral blood flow brain scans using PET with H215O demonstrate ketamine actions in CNS dynamically HH Holcomb, AC Lahti, DR Medoff, M Weiler, CA Tamminga Neuropsychopharmacology 25 (2), 165-172, 2001 | 182 | 2001 |
Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers JF Artaloytia, C Arango, A Lahti, J Sanz, A Pascual, P Cubero, D Prieto, ... American Journal of Psychiatry 163 (3), 488-493, 2006 | 178 | 2006 |
Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia AC Lahti, MA Weiler, HH Holcomb, CA Tamminga, WT Carpenter, ... Neuropsychopharmacology 31 (1), 221-230, 2006 | 176 | 2006 |
Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia JA Hadley, R Nenert, NV Kraguljac, MS Bolding, DM White, FM Skidmore, ... Neuropsychopharmacology 39 (4), 1020-1030, 2014 | 165 | 2014 |
Functional effects of antipsychotic drugs: comparing clozapine with haloperidol AC Lahti, HH Holcomb, MA Weiler, DR Medoff, CA Tamminga Biological psychiatry 53 (7), 601-608, 2003 | 157 | 2003 |
How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference KL Cropsey, LR Trent, CB Clark, EN Stevens, AC Lahti, PS Hendricks Nicotine & Tobacco Research 16 (10), 1348-1355, 2014 | 146 | 2014 |
Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia MA Reid, LE Stoeckel, DM White, KB Avsar, MS Bolding, NS Akella, ... Biological psychiatry 68 (7), 625-633, 2010 | 146 | 2010 |
Multimodal neuroimaging based classification of autism spectrum disorder using anatomical, neurochemical, and white matter correlates LE Libero, TP DeRamus, AC Lahti, G Deshpande, RK Kana Cortex 66, 46-59, 2015 | 145 | 2015 |
Antipsychotic properties of the partial dopamine agonist (−)-3-(3-hydroxyphenyl)-Nn-propylpiperidine (preclamol) in schizophrenia AC Lahti, MA Weiler, PK Corey, RA Lahti, A Carlsson, CA Tamminga Biological psychiatry 43 (1), 2-11, 1998 | 137 | 1998 |